Naters, Switzerland

Thomas Ruppen

This inventor holds 2 USPTO granted patents. Top assignee: Lonza Ag. Active years: 2005-2007.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2005-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas Ruppen: Innovator in Biochemical Methods

Introduction

Thomas Ruppen is a notable inventor based in Naters, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of methods for synthesizing various compounds. With a total of 2 patents to his name, Ruppen's work is recognized for its innovative approaches and practical applications.

Latest Patents

Ruppen's latest patents include a method for preparing β-alaninamides and cyanoacetamides, along with their corresponding salts. These compounds are essential in various biochemical applications. His patents also cover the synthesis of N-(cyanoacetyl)-L-histidines and N-(cyanoacetyl)-3-methyl-L-histidines, which are valuable in dietary supplements due to their antioxidative properties. The methods he developed allow for the production of these compounds without the use of amino-protective groups, enhancing efficiency in their synthesis.

Career Highlights

Thomas Ruppen is currently employed at Lonza AG, a leading global provider of integrated solutions for the pharmaceutical and biotechnology industries. His work at Lonza AG has allowed him to focus on innovative methods that contribute to advancements in biochemistry and related fields.

Collaborations

Ruppen has collaborated with notable colleagues, including Dario Veghini and Stefan Hildbrand. These collaborations have fostered a productive environment for innovation and research, leading to significant advancements in their respective fields.

Conclusion

Thomas Ruppen's contributions to biochemistry through his patents and work at Lonza AG highlight his role as an influential inventor. His innovative methods for synthesizing important biochemical compounds continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…